|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.29 USD | -1.42% |
|
+0.80% | +11.91% |
| 16/07 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| 14/07 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 198B | |||||
| 1,051B | |||||
| 609B | |||||
| 450B | |||||
| 330B | |||||
| 284B |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
